Procter & Gamble Falls After Flat Organic Sales and a Cautious 2027 Outlook

Procter & Gamble (PG) was down about 3% in afternoon trading on Wednesday after fiscal fourth-quarter results paired steady profit with a revenue shortfall and guidance that sat below Wall Street’s forecasts. The stock slipped 2.5% at the open. The losses grew from there. It was a rare wobble for one of the market’s steadiest names.

Sales missed and organic growth stalled

For the quarter that ended in June, P&G reported net sales of $21.2 billion, up 2% from a year earlier but short of the $21.4 billion analysts had modeled. Organic sales, which strip out currency swings, acquisitions and divestitures, were unchanged from the prior year. Core earnings came in at $1.43 a share, down 3% and a touch above the $1.41 consensus. On a reported basis, diluted earnings fell 15% to $1.26 a share, and net earnings were $3.1 billion.

The full year told a milder story. Sales rose 3% to $87.0 billion, organic sales grew 1%, and core earnings edged up 1% to $6.89 a share. Chief Executive Shailesh Jejurikar called fiscal 2026 “a year of foundation building” through what he described as a challenging economic backdrop.

Next year’s targets sit below the Street

The outlook did most of the damage. For fiscal 2027, P&G guided to organic sales growth of 1% to 3% and core earnings of $6.89 to $7.11 a share. The midpoint of that profit range, $7.00, falls just under the $7.02 analysts had penciled in, and the sales target trails the growth Wall Street had modeled. The company also said it expects to pay around $10 billion in dividends over the year.

Finance chief Andre Schulten, in comments reported by financial outlets, described the consumer as stable while flagging a split in behavior: higher-income shoppers keep buying newer products, while lower-income households stay cautious about restocking. That divergence, alongside currency and input-cost pressure, frames a year the company is positioning as gradual.

A defensive name that had gone quiet

P&G came into the report trading at $148.88, about where it sat a month earlier and up 3% over the past 90 days. The shares had been sitting 2.5% below their three-month high and well under a 52-week high of $167.25 set earlier in the year. At a market value of $338 billion, P&G ranks among the largest consumer-staples companies in the market, the kind of holding investors reach for when they want steadiness rather than growth.

Staples stocks trade heavily on pricing power and volume, and P&G’s flat organic line speaks to both. Shoppers did not buy more. Volume added nothing to the quarter’s growth, meaning the modest sales gain came from price and mix while unit sales held flat.

What to watch

The fiscal 2027 targets are now the reference point: whether organic growth climbs back toward the top of the 1% to 3% band, and whether volumes turn positive again. The calendar is crowded this afternoon. Investors weighing P&G’s results also face a Federal Reserve rate decision due later Wednesday and a wave of large-cap earnings landing after the close, any of which can reset the tone before P&G’s own numbers have time to settle.

This is a general-market summary for information only — not investment advice, and not a recommendation regarding any security.